New Science, New Guidance: Rethinking Hepatitis B Vaccination at Birth
Failed to add items
Add to cart failed.
Add to wishlist failed.
Remove from wishlist failed.
Follow podcast failed
Unfollow podcast failed
-
Narrated by:
-
Written by:
About this listen
Send us a text
In this episode of Decoding Health, we examine a recent shift in CDC guidance regarding hepatitis B vaccination recommendations for newborns. Long criticized for lagging behind evolving science, the CDC has now revised its position after reviewing updated risk-benefit data presented during a publicly broadcast panel discussion.
Sparked by the birth of the host’s second grandchild, the conversation breaks down how hepatitis B is transmitted, why infection risk for infants born to hepatitis-negative mothers is extremely low, and what new evidence prompted the CDC to remove its universal newborn recommendation in these cases. We explore the concept of biological immune burden, emerging discussions around neurodevelopmental risk, and why updated guidance may take time to reach hospitals and pediatric practices.
This episode equips parents and healthcare consumers with the knowledge needed to advocate for informed decision-making during postpartum care, using primary-source evidence directly from CDC proceedings.
Are you eager to explore more about health and wellness? Discover an all natural solution to combating the GLP-1 Receptor Agonist craze. Click on the link below and explore the Feel Great System - a clinically proven approach to boosting natural GLP-1 production, suppressing appetite and improving both your metabolism and weight.
https://ufeelgreat.com/usa/en/c/LiveFree
As a Decoding Health viewer, you get wholesale pricing and a money back guarantee. Give it a try and let us know your results.
https://imbiopharma.com/
https://www.linkedin.com/in/urban-a-kiernan-ph-d-8568b621/
https://www.youtube.com/@DecodingHealthPodcast
Thank you to our sponsor - iMetabolic Biopharma Corporation: Together, we can be the next stage in developing a revolutionary approach to drug discovery. We give communities the opportunity to invest in their own health as we improve how drugs are discovered to make them more effective and affordable. Visit https://imbiopharma.com/ to learn more.